Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 6:14 PM View:  | Dow Geoffrey S President and CEO Director | 60 Degrees Pharmaceuticals,... (SXTP) | Yesterday | Purchase | 3,500 | $0.91 | $3,195.15 | 5% 72.72K to 76.22K | |
| Yesterday 6:14 PM View: | Dow Geoffrey S President and CEO Director | 60 Degrees Pharmaceuticals,... (SXTP) | 20-Nov-24 | Purchase | 1,000 | $0.92 | $924.30 | 1% 71.72K to 72.72K | |
| Yesterday 6:14 PM View: | Dow Geoffrey S President and CEO Director | 60 Degrees Pharmaceuticals,... (SXTP) | 19-Nov-24 | Purchase | 2,500 | $0.90 | $2,248.00 | 4% 69.22K to 71.72K | |
| 11-Sep-24 4:46 PM View: | Xu Cheryl Director | 60 Degrees Pharmaceuticals,... (SXTP) | 27-Aug-24 | Purchase | 5,000 | $1.70 | $8,500.00 | 14% 36.08K to 41.08K | |
| 21-May-24 8:23 PM View: | Toovey Stephen Director | 60 Degrees Pharmaceuticals,... (SXTP) | 16-May-24 | Grant | 4,000 | $0.22 | $892.00 | 40% 10.0K to 14.0K | |
| 21-May-24 8:20 PM View: | Field Paul Director | 60 Degrees Pharmaceuticals,... (SXTP) | 16-May-24 | Option Exercise | 4,000 | $0.22 | $892.00 | 40% 10.0K to 14.0K | |
| 21-May-24 8:18 PM View: | Allen Charles W Director | 60 Degrees Pharmaceuticals,... (SXTP) | 16-May-24 | Option Exercise | 4,000 | $0.22 | $892.00 | 40% 10.0K to 14.0K | |
| 21-May-24 8:23 PM View: | Xu Cheryl Director | 60 Degrees Pharmaceuticals,... (SXTP) | 16-May-24 | Option Exercise | 2,000 | $0.22 | $446.00 | < 1% 226.93K to 228.93K | |
| 21-May-24 8:22 PM View: | Miller Tyrone CFO | 60 Degrees Pharmaceuticals,... (SXTP) | 16-May-24 | Grant | 15,000 | $0.22 | $3,345.00 | 9% 161.93K to 176.93K | |
| 21-May-24 8:19 PM View: | Dow Geoffrey S President and CEO Director | 60 Degrees Pharmaceuticals,... (SXTP) | 16-May-24 | Option Exercise | 17,000 | $0.22 | $3,791.00 | 1% 1.49M to 1.51M | |
| 21-May-24 8:19 PM View: | Dow Geoffrey S President and CEO Director | 60 Degrees Pharmaceuticals,... (SXTP) | 12-Apr-24 | Option Exercise | 68,000 | $0.27 | $18,142.40 | 5% 1.42M to 1.49M | |
| 21-May-24 8:22 PM View: | Miller Tyrone CFO | 60 Degrees Pharmaceuticals,... (SXTP) | 12-Apr-24 | Grant | 60,000 | $0.27 | $16,008.00 | 59% 101.93K to 161.93K | |
| 02-Feb-24 3:31 PM View: | Xu Cheryl Director | 60 Degrees Pharmaceuticals,... (SXTP) | 01-Feb-24 | Option Exercise | 2,000 | -- | -- | 50% 4.0K to 6.0K | |
| 02-Feb-24 3:33 PM View: | Dow Geoffrey S President and CEO Director | 60 Degrees Pharmaceuticals,... (SXTP) | 31-Jan-24 | Purchase | 25,974 | $0.38 | $9,740.25 | 4% 677.63K to 703.6K | |
| 02-Feb-24 3:31 PM View: | Xu Cheryl Director | 60 Degrees Pharmaceuticals,... (SXTP) | 31-Jan-24 | Purchase | 200,000 | $0.38 | $75,000.00 | 89% 224.93K to 424.93K | |
| 03-Apr-24 6:00 PM View: | Knight Therapeutics Inc | 60 Degrees Pharmaceuticals,... (SXTP) | 28-Jul-23 | Conversion | 45,560 | $4.74 | $216,182.00 | 4% 1.19M to 1.23M | |
| 03-Apr-24 6:00 PM View: | Knight Therapeutics Inc | 60 Degrees Pharmaceuticals,... (SXTP) | 28-Jul-23 | Conversion | 2,162 | -- | -- | (< 1%) 1.23M to 1.23M |
